Publication:
Epidemiology of candida infections in HRH princess maha chakri sirindhorn medical center, srinakharinwirot university

dc.contributor.authorTantisiriwat W.
dc.contributor.authorSantiwattanakul S.
dc.date.accessioned2021-04-05T03:25:10Z
dc.date.available2021-04-05T03:25:10Z
dc.date.issued2015
dc.date.issuedBE2558
dc.description.abstractObjective: To identify the epidemiology of candida isolations in HRH Princess Maha Chakri Sirindhorn Medical Center and the sensitivity of all candida species to fluconazole. Material and Method: Two hundred of Candida albicans and other Candida species from clinical specimens were collected from microbiological department between January 2010 and April 2012. All Candida were identified by standard methods and the sensitivity of fluconazole was tested by using fluconazole E test test. Results: There were 8 species of Candida in this study including: C. albicans (n = 94), C. tropicalis (n = 66), C. glabrata (n = 11), C. guilliermondii (n = 10), C. parapsilosis (n = 9), C. zeylanoides (n = 4), C. keyfr (C. pseudotropicalis) (n = 2), C. lusitaniae (n = 1), Candida species (n = 3). The percentage of non-albicans Candida spp. was slightly higher than C. albicans (53% vs. 47%). C. tropicalis was identified as the highest percentage of all non-albicans Candida spp. Fluconazole resistant strains were detected among C. albicans (35.71%), C. tropicalis (13.85%), C. guilliermondii (20.0%), and C. zeylanoides (50.0%). The common spp. with highest percentage of resistant strain was C. albicans. Conclusion: Fluconazole could be used as the first-line antifungal for candidiasis at HRH Princess Maha Chakri Sirindhorn Medical Center. Empirical treatment with amphotericin B and stepping down to fluconazole when sensitivity suggested might be the recommendation for severe cases in our setting. © 2015, Medical Association of Thailand. All rights reserved.
dc.format.mimetypeapplication/pdf
dc.identifier.citationJournal of the Medical Association of Thailand. Vol 98, (2015), p.S66-S70
dc.identifier.issn1252208
dc.identifier.other2-s2.0-84957716993
dc.identifier.urihttps://hdl.handle.net/20.500.14740/6050
dc.rights.holderScopus
dc.subject.otherAmphotericin B
dc.subject.otherFluconazole
dc.subject.otherAmphotericin B
dc.subject.otherAntifungal agent
dc.subject.otherFluconazole
dc.subject.otherAntibiotic sensitivity
dc.subject.otherArticle
dc.subject.otherCandida albicans
dc.subject.otherCandida glabrata
dc.subject.otherCandida parapsilosis
dc.subject.otherCandida tropicalis
dc.subject.otherCandida zeylanoides
dc.subject.otherCandidemia
dc.subject.otherCandidiasis
dc.subject.otherClavispora lusitaniae
dc.subject.otherKluyveromyces marxianus
dc.subject.otherMeyerozyma guilliermondii
dc.subject.otherMinimum inhibitory concentration
dc.subject.otherNonhuman
dc.subject.otherProspective study
dc.subject.otherSensitivity analysis
dc.subject.otherCandida
dc.subject.otherCandidiasis
dc.subject.otherHuman
dc.subject.otherIsolation and purification
dc.subject.otherMicrobial sensitivity test
dc.subject.otherProcedures
dc.subject.otherUnited States
dc.subject.otherUniversity hospital
dc.subject.otherAcademic Medical Centers
dc.subject.otherAmphotericin B
dc.subject.otherAntifungal Agents
dc.subject.otherCandida
dc.subject.otherCandida albicans
dc.subject.otherCandidiasis
dc.subject.otherFluconazole
dc.subject.otherHumans
dc.subject.otherMicrobial Sensitivity Tests
dc.subject.otherProspective Studies
dc.subject.otherUnited States
dc.titleEpidemiology of candida infections in HRH princess maha chakri sirindhorn medical center, srinakharinwirot university
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84957716993&partnerID=40&md5=60b202cacabbfe993878296c9877b11d

Files